Medpace Holdings, Inc. (MEDP)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,148	10,303	9,405	6,589	7,782	4,952
Market Cap Growth	-29.15%	9.54%	42.75%	-15.33%	57.15%	64.49%
Enterprise Value	13,251	9,798	9,474	6,855	7,526	4,858
Last Close Price	468.00	332.23	306.53	212.41	217.64	139.20
PE Ratio	34.78	25.48	33.28	26.87	42.90	34.17
Forward PE	31.48	27.33	31.74	27.33	42.23	31.38
PS Ratio	6.34	4.89	4.99	4.51	6.81	5.35
PB Ratio	76.08	12.48	16.83	17.05	8.17	6.15
P/TBV Ratio	-	80.00	-	-	31.23	51.10
P/FCF Ratio	22.68	18.00	23.71	18.76	33.10	21.78
P/OCF Ratio	21.41	16.92	21.70	16.98	29.55	19.14
PEG Ratio	2.77	1.52	1.52	1.52	1.52	1.52
EV/Sales Ratio	5.94	4.65	5.02	4.70	6.59	5.25
EV/EBITDA Ratio	26.16	20.58	26.09	22.77	34.25	26.04
EV/EBIT Ratio	27.75	21.93	28.13	24.60	37.89	29.08
EV/FCF Ratio	22.85	17.12	23.88	19.52	32.02	21.37
Debt / Equity Ratio	0.87	0.18	0.29	0.54	0.16	0.16
Debt / EBITDA Ratio	0.27	0.29	0.41	0.62	0.59	0.62
Debt / FCF Ratio	0.26	0.26	0.42	0.59	0.63	0.58
Asset Turnover	1.28	1.12	1.25	0.97	0.75	0.73
Quick Ratio	0.35	0.90	0.60	0.37	1.16	1.00
Current Ratio	0.43	0.93	0.64	0.42	1.24	1.08
Return on Equity (ROE)	89.39%	58.42%	59.83%	36.64%	20.68%	18.98%
Return on Assets (ROA)	17.09%	14.87%	13.99%	11.56%	8.14%	8.24%
Return on Capital (ROIC)	48.16%	32.89%	31.95%	20.56%	12.19%	12.14%
Return on Capital Employed (ROCE)	136.00%	44.90%	46.00%	50.80%	18.00%	17.60%
Earnings Yield	3.18%	3.92%	3.01%	3.72%	2.34%	2.94%
FCF Yield	4.41%	5.55%	4.22%	5.33%	3.02%	4.59%
Buyback Yield / Dilution	2.69%	-0.54%	5.44%	10.68%	0.03%	-0.35%

Updated Jul 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q